EVERY DAY MATTERS

Alexion Pharmaceuticals, Inc.

Application Filed: 2001-09-26
Trademark Application Details
Trademark Logo EVERY DAY MATTERS

Mark For: EVERY DAY MATTERS™ trademark registration is intended to cover the categories of pharmaceuticals used in treatment of cardiovascular, autoimmune, and neurological diseases, cancer, and xenographic transplants. [all]

Status

2022-08-14 UTC
DEAD APPLICATION Refused Dismissed or Invalidated
This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.


Research OneLook Acronym Finder
Serial Number76320056
Mark Literal ElementsEVERY DAY MATTERS
Mark Drawing Type1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark TypeTRADEMARK
Standard Character ClaimNo
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2004-12-16
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NamePaul D. Greeley
Attorney Docket Number192.7462UST1
Law Office AssignedL50
Employee NameESTRADA, LINDA M

Timeline

2001-09-26Application Filed
2002-03-19Published
2002-03-19Published for Opposition
2004-12-16Location: INTENT TO USE SECTION
2005-06-12Abandon
2005-06-12Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume
2005-06-12Status: Dead/Abandoned
2018-07-08Transaction Date

Trademark Parties (Applicants & Owners)

Party: Alexion Pharmaceuticals, Inc.
Address352 Knotter Drive Cheshire, CONNECTICUT UNITED STATES 06410
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

ApplicationIMAGE/TIFF2001-09-26
DrawingIMAGE/TIFF2001-09-26
Duplicate Application2001-09-26
Duplicate Drawing2001-09-26
XSearch Search Summary2001-12-08
Unclassified-Other2002-01-14
Notice of Publication2002-02-27
Notice of Allowance2002-06-11
Extension of Time to File SOU2002-12-05
Paper Correspondence Incoming2002-12-05
Extension of Time to File SOU2003-03-17
Extension of Time to File SOU2003-03-17
Extension of Time to File SOU2003-05-23
Extension of Time to File SOU2003-05-23
Paper Correspondence Outgoing2003-06-09
Extension of Time to File SOU2003-12-04
Extension of Time to File SOU2003-12-04
Specimen2003-12-04
Statement of Use2003-12-04
Paper Correspondence Incoming2003-12-08
Request to Divide2003-12-08
Offc Action Outgoing2004-02-03
ITU Extension ApprovalAPPLICATION/XML2004-02-04
Extension of Time to File SOU2004-06-11
Extension of Time to File SOUAPPLICATION/XML,IMAGE/TIFF2004-06-11
File Jacket2004-06-16
Unclassified-Other2004-06-16
ITU Extension ApprovalAPPLICATION/XML2004-06-25
Extension of Time to File SOU2004-12-09
ITU Extension Approval2004-12-17
Notice of Abandonment2005-09-29

Attorney of Record

PAUL D. GREELEY
OHLANDT, GREELEY, RUGGIERO & PERLE, LLP
1 LANDMARK SQ FL 10
STAMFORD CT 06901-2620

Good, Services, and Codes

(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceuticals used in treatment of cardiovascular, autoimmune, and neurological diseases, cancer, and xenographic transplants

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceuticals used in treatment of cardiovascular, autoimmune, and neurological diseases, cancer, and xenographic transplants

Trademark Filing History

DescriptionDateProceeding Number
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED2005-09-29
ABANDONMENT - NO USE STATEMENT FILED2005-09-2948294
SOU EXTENSION 5 GRANTED2004-12-1566121
TEAS EXTENSION RECEIVED2004-12-09
SOU EXTENSION 5 FILED2004-12-0966121
SOU EXTENSION 4 GRANTED2004-06-24
CASE FILE IN TICRS2004-06-17
TEAS EXTENSION RECEIVED2004-06-11
SOU EXTENSION 4 FILED2004-06-11
ASSIGNED TO EXAMINER2004-04-2676795
SOU EXTENSION 3 GRANTED2004-02-03
DIVISIONAL PROCESSING COMPLETE2004-02-03
PAPER RECEIVED2003-12-08
DIVISIONAL REQUEST RECEIVED2003-12-08
TEAS STATEMENT OF USE RECEIVED2003-12-04
TEAS EXTENSION RECEIVED2003-12-04
SOU EXTENSION 3 FILED2003-12-04
TEAS EXTENSION RECEIVED2003-05-23
SOU EXTENSION 2 GRANTED2003-05-16
TEAS EXTENSION RECEIVED2003-03-17
SOU EXTENSION 2 FILED2003-03-17
SOU EXTENSION 1 GRANTED2003-02-25
SOU EXTENSION 1 FILED2002-12-05
PAPER RECEIVED2002-12-05
NOA MAILED - SOU REQUIRED FROM APPLICANT2002-06-11
PUBLISHED FOR OPPOSITION2002-03-19
NOTICE OF PUBLICATION2002-02-27
APPROVED FOR PUB - PRINCIPAL REGISTER2001-12-12
ASSIGNED TO EXAMINER2001-12-0778488

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed